Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines
- 16 August 2000
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 11 (3) , 207-214
- https://doi.org/10.1016/s0928-0987(00)00097-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- BBB Transport and P-glycoprotein Functionality Using MDR1A (-/-) and Wild-Type Mice. Total Brain Versus Microdialysis Concentration Profiles of Rhodamine-123Pharmaceutical Research, 1998
- Rhodamine 123 accumulates extensively in the isolated perfused rat kidney and is secreted by the organic cation systemEuropean Journal of Pharmacology, 1997
- Is Rhodamine 123 an Appropriate Fluorescent Probe to Assess P-Glycoprotein Mediated Multidrug Resistance in Vinblastine-Resistant CHO Cells?Analytical Cellular Pathology, 1997
- Age-dependent Expression of P-Glycoprotein gp17O in Caco-2 Cell MonolayersPharmaceutical Research, 1996
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cellsCell, 1991
- Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.Journal of Histochemistry & Cytochemistry, 1990
- Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastineBiochemical and Biophysical Research Communications, 1988